| Literature DB >> 31721432 |
Philip J Ostrowski1, Anna Zachariou2, Chey Loveday3, Ana Beleza-Meireles4, Marta Bertoli5, John Dean6, Andrew G L Douglas7,8, Ian Ellis9, Alison Foster10,11, John M Graham12,13, Jennifer Hague14, Yvonne Hilhorst-Hofstee15, Mariette Hoffer15, Diana Johnson16, Dragana Josifova4, Sarina G Kant15, Usha Kini17, Katherine Lachlan7, Wayne Lam18, Melissa Lees19, Sally Lynch20, Silvia Maitz21, Shane McKee22, Kay Metcalfe23, Katherine Nathanson24, Charlotte W Ockeloen25, Michael J Parker16, Tyler M Pierson26, Elisa Rahikkala27, Pedro A Sanchez-Lara12,13, Alice Spano21, Lionel Van Maldergem28,29, Trevor Cole11, Sofia Douzgou30,31, Katrina Tatton-Brown1,32.
Abstract
CHD8 has been reported as an autism susceptibility/intellectual disability gene but emerging evidence suggests that it additionally causes an overgrowth phenotype. This study reports 27 unrelated patients with pathogenic or likely pathogenic CHD8 variants (25 null variants, two missense variants) and a male:female ratio of 21:6 (3.5:1, p < .01). All patients presented with intellectual disability, with 85% in the mild or moderate range, and 85% had a height and/or head circumference ≥2 standard deviations above the mean, meeting our clinical criteria for overgrowth. Behavioral problems were reported in the majority of patients (78%), with over half (56%) either formally diagnosed with an autistic spectrum disorder or described as having autistic traits. Additional clinical features included neonatal hypotonia (33%), and less frequently seizures, pes planus, scoliosis, fifth finger clinodactyly, umbilical hernia, and glabellar hemangioma (≤15% each). These results suggest that, in addition to its established link with autism and intellectual disability, CHD8 causes an overgrowth phenotype, and should be considered in the differential diagnosis of patients presenting with increased height and/or head circumference in association with intellectual disability.Entities:
Keywords: CHD8; intellectual disability; macrocephaly; overgrowth
Mesh:
Substances:
Year: 2019 PMID: 31721432 DOI: 10.1002/ajmg.c.31749
Source DB: PubMed Journal: Am J Med Genet C Semin Med Genet ISSN: 1552-4868 Impact factor: 3.359